Liam McMorrow
Impact in
- Infectious Diseases top 0.5%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Neurology top 1%
- Long-Term Effects of COVID-19
Papers in
-
- COVID-19 Clinical Research Studies 19
- SARS-CoV-2 and COVID-19 Research 3
- Neurology 10
- Long-Term Effects of COVID-19 10
- Co-authors
- Seán F. Dinneen (1 shared paper)
- Journals
- The Lancet (6 papers)JAMA (6 papers)The Lancet Respiratory Medicine (5 papers)Nature (4 papers)EClinicalMedicine (2 papers)
- Partner nations
- United KingdomIrelandVietnam
In The Last Decade
Liam McMorrow
35 papers receiving 4.5k citations
Liam McMorrow's Hit Papers
Peers
Comparison fields: 5 of 115
- Infectious Diseases 2.4k
- Neurology 928
- Genetics 519
- Internal Medicine 48
- Applied Microbiology and Biotechnology 35
Countries citing papers authored by Liam McMorrow
This map shows the geographic impact of Liam McMorrow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liam McMorrow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liam McMorrow more than expected).
Fields of papers citing papers by Liam McMorrow
This network shows the impact of papers produced by Liam McMorrow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liam McMorrow. The network helps show where Liam McMorrow may publish in the future.
Co-authors
The 1 scholars most cited alongside Liam McMorrow, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Mapping the human genetic architecture of COVID-19 Hit paper breakdown → | 2021 | 656 |
| 2 | Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study Hit paper breakdown → | 2021 | 504 |
| 3 | Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 411 |
| 4 | Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial Hit paper breakdown → | 2021 | 393 |
| 5 | Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study Hit paper breakdown → | 2022 | 310 |
| 6 | Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2022 | 282 |
| 7 | Effect of Noninvasive Respiratory Strategies on Intubation or Mortality Among Patients With Acute Hypoxemic Respiratory Failure and COVID-19 Hit paper breakdown → | 2022 | 252 |
| 8 | Whole-genome sequencing reveals host factors underlying critical COVID-19 Hit paper breakdown → | 2022 | 233 |
| 9 | Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis Hit paper breakdown → | 2022 | 231 |
| 10 | 2021 | 213 | |
| 11 | 2021 | 166 | |
| 12 | GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19 Hit paper breakdown → | 2023 | 125 |
| 13 | 2022 | 105 | |
| 14 | 2022 | 100 | |
| 15 | 2022 | 87 | |
| 16 | Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2023 | 84 |
| 17 | 2021 | 72 | |
| 18 | Large-scale phenotyping of patients with long COVID post-hospitalization reveals mechanistic subtypes of disease Hit paper breakdown → | 2024 | 65 |
| 19 | 2023 | 60 | |
| 20 | 2023 | 46 |
About Liam McMorrow
Liam McMorrow is a scholar working on Infectious Diseases, Neurology, Genetics, Geriatrics and Gerontology and Nutrition and Dietetics, having authored 36 papers that have together received 4.6k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (19 papers), Long-Term Effects of COVID-19 (10 papers), Genetic Associations and Epidemiology (6 papers), SARS-CoV-2 and COVID-19 Research (3 papers), Sleep and related disorders (1 paper), Frailty in Older Adults (1 paper), Kawasaki Disease and Coronary Complications (1 paper) and Vitamin C and Antioxidants Research (1 paper). The work is most often cited by research in Infectious Diseases (2.4k citations), Neurology (928 citations), Genetics (519 citations), Internal Medicine (48 citations) and Applied Microbiology and Biotechnology (35 citations). Liam McMorrow has collaborated with scholars based in United Kingdom, Ireland and Vietnam. Frequent co-authors include Seán F. Dinneen. Their work appears in journals such as The Lancet, JAMA, The Lancet Respiratory Medicine, Nature and EClinicalMedicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.